311
Views
13
CrossRef citations to date
0
Altmetric
Original article

Macular Abnormalities in Vogt-Koyanagi-Harada Disease

, MD, PhD, , MD, PhD, , BS, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , BA, , MS, , MD, PhD & , PhD show all
Pages 1195-1202 | Received 09 Apr 2019, Accepted 24 May 2019, Published online: 15 Aug 2019
 

ABSTRACT

Purpose: To investigate the prevalence of macular abnormalities in Chinese Vogt-Koyanagi-Harada (VKH) patients.

Methods: Clinical characteristics, therapeutic effectiveness and visual outcome were reviewed and analyzed.

Results: The most common macular abnormality was macular edema (ME), followed by macular choroidal neovascularization (CNV). Macular abnormalities were associated with recurrent episodes, disease course and visual acuity ≤20/50 at first visit. The prevalence of macular abnormalities in patients who were not treated according to our regular treatment regimen with corticosteroids combined with immunosuppressive agents and who were followed-up for at least one year (13.1%) was significantly higher than in patients receiving the regular treatment (5.7%). Visual improvement was found in 66.7% of eyes with macular abnormalities after regular treatment.

Conclusion: Macular abnormalities were associated with recurrent uveitis, course of disease and lower visual acuity at first visit. Regular treatment could prevent the development of macular abnormalities and improved visual outcome in most patients.

Acknowledgments

This work was supported by Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Innovation project of Chongqing Science & Technology commission (cstc2017shmsA130073), Key Project of Health Bureau of Chongqing (2012-1-003) and Chongqing Science & Technology Platform and Base Construction Program (cstc2014pt-sy10002).

We thank all the patients who participated in this study.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Supplemental material

Supplementary data for this article can be accessed here

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.